Sanofi to collaborate with Mass General on cancer drug development; Foundation Medicine inks development past with Eisai;

 @FierceBiotech: Fight against 'unwarranted' drug patents goes online. FierceBiotechIT article | Follow @FierceBiotech

 @JohnCFierce: Interesting. Twitter conclusion: Solanezumab a complete bust. But on BMBG, Reuters etc., it's an intriguing "win" for patients. Disconnect. | Follow @JohnCFierce

 @RyanMFierce: Magic Johnson is using his celebrity to bring attention to OraSure's at-home HIV test. A good use of his celebrity, I think.  | Follow @RyanMFierce

> Investigators from Sanofi ($SNY) and Massachusetts General Hospital in Boston will collaborate on a translational medicine project for new cancer therapies. The two-year pact brings together academic and industry professional in preclinical and clinical development work. Sanofi's global oncology group is based in Cambridge, MA. Release

> The 2012 Fierce 15 biotech Foundation Medicine has signed on Eisai to one of its multi-year collaborations on selecting cancer patients for drug studies. This is the latest in a series of pacts with drug developers. Release

> The Danish biotech Veloxis Pharmaceuticals has inked a $47.7 million distribution pact with Italy's Chiesi. Story

Pharma News

@FiercePharma: Scotland rejects Avastin for ovarian cancer. Roche says the Scots need a cancer-drugs fund like England's. Report | Follow @FiercePharma

> J&J eyes new Doxil process to reverse shortage. Story

> Roche: Scotland needs funding for rejected cancer meds. Article

> Merck plots HQ move to former Schering site. More

Medical Device News

 @FierceMedDev: AngioDynamics has agreed to purchase Vortex Medical for $55M. News | Follow @FierceMedDev

 @MarkHFierce: Stem cells derived from skin to be tested in humans as eye disease treatment--via Bloomberg. Article | Follow @MarkHFierce

 @DamianFierce: Boston Scientific will pay up to $265M for Rhythmia Medical. News | Follow @DamianFierce

> Edwards plunges on the Street as sales come up short. News

> Accutron recalls flowmeters over gas risk. Item

Pharma Manufacturing News

> Compounder tied to meningitis deaths sold large quantities. News

> Sanofi Pasteur reports more issues with vaccine quality. Story

> Mold found in Hospira dextrose solution. Report

Biotech Research News

> Japanese scientists weld stem cells to create eggs and then baby mice. More

> RXi gains SBIR grant to pursue RNAi eye cancer drug. News

> Athersys stem cell therapy displays power as MS treatment. Article

> Inovio preclinical results prove skin delivery potency for DNA vaccines. Story

And Finally… A new study indicates that lycopene, an antioxidant found in tomatoes, is associated with a significantly lower risk of stroke among men. The study tracked more than 1,000 Finnish men for more than 12 years. Story